Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development

References

• Kube DA, Petersen MC, Palmer FB. Attention deficit hyperactivity disorder: comorbidity and medication use. Clin. Pediatr.41(7), 461–469 (2002).
   PubMed Web of Science ®Google Scholar
• Rowland AS, Umbach DM, Stallone L et al. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am. J. Public Health92(2), 231–234 (2002).
   PubMed Web of Science ®Google Scholar
• Connor DF. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. J. Dev. Behav. Pediatr.23(Suppl. 1), S1–S9 (2002).
   Web of Science ®Google Scholar
• Smucker WD, Hedayat M. Evaluation and treatment of ADHD. Am. Fam. Physician64(5), 817–829 (2001).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J. Am. Acad. Child Adolesc. Psychiatry35(3), 264–272 (1996).
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry46(9), 1234–1242 (1999).
   PubMed Web of Science ®Google Scholar
• Clarke AR, Barry RJ, McCarthy R, Selikowitz M. EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clin. Neurophysiol.113(2), 194–205 (2002).
   PubMed Web of Science ®Google Scholar
• Chabot RJ, Orgill A, Crawford G, Harris M, Serfontein G. Behavioral and electrophysiological predictors of treatment response to stimulants in children with attention disorders. J. Child Neurol.14, 343–351 (1999).
   PubMed Web of Science ®Google Scholar
• Johnstone J, Gunkelman J, Lunt J. Clinical database development: characterization of EEG phenotypes. Clin. EEG Neurosci.36(2), 99–107 (2005).
   PubMed Web of Science ®Google Scholar
• Lubar JF, White JN Jr, Swartwood MO, Swartwood JN. Methylphenidate effects on global and complex measures of EEG. Pediatr. Neurol.21(3), 633–637 (1999).
   PubMed Web of Science ®Google Scholar
• Clarke AR, Barry RJ, McCarthy R et al. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder predominantly inattentive type. Int. J. Psychophysiol.47(2), 129–137 (2003).
   PubMed Web of Science ®Google Scholar
• Hermens DF, Rowe DL, Gordon E, Williams LM. Integrative neuroscience approach to predict ADHD stimulant response. Expert Rev. Neurother.6(5), 753–763 (2006).
   PubMed Web of Science ®Google Scholar
• Lin SJ, Crawford SY, Lurvey PL. Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan. Social Sci. Med.60(3), 617–626 (2005).
   PubMed Web of Science ®Google Scholar
• Bonati M, Clavenna A. The epidemiology of psychotropic drug use in children and adolescents. Int. Rev. Psychiatry17(3), 181–188 (2005).
   PubMed Web of Science ®Google Scholar
• Sangal RB, Sangal JM. What is a significant response in drug studies of attention-deficit/hyperactivity disorder: statistical significance is necessary, but is it sufficient? Psychopharmacol. Bull.37(2), 50–58 (2003).
   PubMedGoogle Scholar
• Sangal RB, Sangal JM. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine. Clin. Neurophysiol.116(3), 640–647 (2005).
   PubMed Web of Science ®Google Scholar
• Greydanus DE, Sloane MA, Rappley MD. Psychopharmacology of ADHD in adolescents. Adolesc. Med.13(3), 599–624 (2002).
   PubMedGoogle Scholar
• Caballero J, Nahata MC. Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clin. Ther.25(12), 3065–3085 (2003).
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int. J. Neuropsychopharmacol.7(1), 77–97 (2004).
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry155(5), 693–695 (1998).
   PubMed Web of Science ®Google Scholar
• Hermens DF, Cooper NJ, Kohn M, Clarke S, Gordon E. Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. J. Integr. Neurosci.4(1), 107–121 (2005).
   PubMedGoogle Scholar
• Loo SK, Teale PD, Reite ML. EEG correlates of methylphenidate response among children with ADHD: a preliminary report. Biol. Psychiatry45(12), 1657–1660 (1999).
   PubMed Web of Science ®Google Scholar
• Clarke AR, Barry RJ, McCarthy R et al. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder predominantly inattentive type. Int. J. Psychophysiol.47(2), 129–137 (2003).
   PubMed Web of Science ®Google Scholar
• Clarke AR, Barry RJ, McCarthy R, Selikowitz M. Excess β activity in children with attention-deficit/hyperactivity disorder: an atypical electrophysiological group. Psychiatry Res.103(2–3), 205–218 (2001).
   PubMed Web of Science ®Google Scholar
• Rowe DL, Rennie CJ, Wright JJ, Robinson PA, Gordon E. Neurochemical mechanisms of theta, P2 & P3 abnormalities in attention deficit hyperactivity disorder (ADHD). Int. J. Psychophysiol.45(1–2), 75–76 (2002).
   Google Scholar
• Levin ED. Nicotinic receptor subtypes and cognitive function. J. Neurobiol.53(4), 633–640 (2002).
   PubMedGoogle Scholar
• Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol. Psychiatry59(11), 1065–1070 (2006).
   PubMed Web of Science ®Google Scholar
• Pichat P, Bergis OE, Terranova JP et al. SSR180711, a novel selective α-7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology (2006) (In press).
   PubMed Web of Science ®Google Scholar
• Hermens DF, Williams LM, Clarke S et al. Responses to methylphenidate in adolescent AD/HD: evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. Int. J. Psychophysiol.58(1), 21–33 (2005).
   PubMed Web of Science ®Google Scholar
• Evans SW, Axelrod J, Langberg JM. Efficacy of a school-based treatment program for middle school youth with ADHD: pilot data. Behav. Modif.28(4), 528–547 (2004).
   PubMed Web of Science ®Google Scholar
• Miranda A, Presentacion MJ. Efficacy of cognitive-behavioral therapy in the treatment of children with ADHD, with and without aggressiveness. Psychol. Sch.37(2), 169–182 (2000).
   Web of Science ®Google Scholar
• Levy F. Implications for Australia of the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Aust. NZJ. Psychiatry35(1), 45–48 (2001).
   PubMed Web of Science ®Google Scholar
• Niedermeyer E, Lopes da Silva FH. Electroencephalography: Basic Principles, Clinical Applications and Related Fields. Williams & Watkins, MD, USA (1999).
   Google Scholar
• Gordon E, Cooper N, Rennie C, Hermens D, Williams LM. Integrative neuroscience: the role of a standardized database. Clin. EEG Neurosci.36(2), 64–75 (2005).
   PubMed Web of Science ®Google Scholar
• Petroff OA. GABA and glutamate in the human brain. Neuroscientist8(6), 562–573 (2002).
   PubMed Web of Science ®Google Scholar
• Suffczynski P, Kalitzin S, Pfurtscheller G, Lopes da Silva FH. Computational model of thalamo-cortical networks: dynamical control of α rhythms in relation to focal attention. Int. J. Psychophysiol.43(1), 25–40 (2001).
   PubMed Web of Science ®Google Scholar
• Thomson AM. Activity dependent properties of synaptic transmission at two classes of connections made by rat neocortical pyramidal neurons in vitro. J. Physiol.502(1), 131–147 (1997).
   PubMed Web of Science ®Google Scholar
• Greengard P. The neurobiology of slow synaptic transmission. Science294(5544), 1024–1030 (2001).
   PubMed Web of Science ®Google Scholar
• Hasselmo ME. Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav. Brain Res.67(1), 1–27 (1995).
   PubMed Web of Science ®Google Scholar
• Gioanni Y, Rougeot C, Clarke PB et al. Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur. J. Neurosci.11(1), 18–30 (1999).
   PubMed Web of Science ®Google Scholar
• Chu ZG, Zhou FM, Hablitz JJ. Nicotinic acetylcholine receptor-mediated synaptic potentials in rat neocortex. Brain Res.887(2), 399–405 (2000).
   PubMed Web of Science ®Google Scholar
• Koós T, Tepper JM. Dual cholinergic control of fast-spiking interneurons in the neostriatum. J. Neurosci.22(2), 529–535 (2002).
   PubMed Web of Science ®Google Scholar
• Sarter M, Bruno JP. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience95(4), 933–952 (2000).
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Isa T. Sensory-motor gating and cognitive control by the brainstem cholinergic system. Neural Networks15(4–6), 731–741 (2002).
   PubMed Web of Science ®Google Scholar
• Jones BE. The organization of central cholinergic systems and their functional importance in sleep-waking states. Prog. Brain Res.98, 61–71 (1993).
   PubMed Web of Science ®Google Scholar
• Jasper HH, Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science172(983), 601–602 (1971).
   PubMed Web of Science ®Google Scholar
• Gross DW, Gotman J. Correlation of high-frequency oscillations with the sleep-wake cycle and cognitive activity in humans. Neuroscience94(4), 1005–1018 (1999).
   PubMed Web of Science ®Google Scholar
• Gray CM, McCormick DA. Chattering cells: superficial pyramidal neurons contributing to the generation of synchronous oscillations in the visual cortex. Science274(5284), 109–113 (1996).
   PubMed Web of Science ®Google Scholar
• Balatoni B, Detari L. EEG related neuronal activity in the pedunculopontine tegmental nucleus of urethane anaesthetized rats. Brain Res.959(2), 304–311 (2003).
   PubMed Web of Science ®Google Scholar
• Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroencephalogr. Clin. Neurophysiol.1(4), 455–473 (1949).
   PubMedGoogle Scholar
• Sakai K, Crochet S. Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake–sleep states. Neuroscience104(4), 1141–1155 (2001).
   PubMed Web of Science ®Google Scholar
• Shouse MN, Staba RJ, Saquib SF, Farber PR. Monoamines and sleep: microdialysis findings in pons and amygdala. Brain Res.860(1–2), 181–189 (2000).
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol. Rev.72(1), 165–229 (1992).
   PubMed Web of Science ®Google Scholar
• Monti JM. Involvement of histamine in the control of the waking state. Life Sci.53(17), 1331–1338 (1993).
   PubMed Web of Science ®Google Scholar
• Reiner PB. Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats. Brain Res.378(1), 86–96 (1986).
   PubMed Web of Science ®Google Scholar
• Hallanger AE, Levey AI, Lee HJ, Rye DB, Wainer BH. The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J. Comp. Neurol.262(1), 105–124 (1987).
   PubMed Web of Science ®Google Scholar
• Semba K, Fibiger HC. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol.323(3), 387–410 (1992).
   PubMed Web of Science ®Google Scholar
• Crabtree JW. Organization in the somatosensory sector of the cat’s thalamic reticular nucleus. J. Comp. Neurol.366(2), 207–222 (1996).
   PubMed Web of Science ®Google Scholar
• Steriade M, Jones EG, McCormick DA. Thalamus. Organisation and Function. Vol. 1, Elsevier, Amsterdam, NY, USA (1997).
   Google Scholar
• Montero VM. Attentional activation of the visual thalamic reticular nucleus depends on ‘top-down’ inputs from the primary visual cortex via corticogeniculate pathways. Brain Res.864(1), 95–104 (2000).
   PubMed Web of Science ®Google Scholar
• Sherman SM, Koch C. Thalamus. In: Synaptic Organization of the Brain. Shepherd GM (Ed.). Oxford University Press, NY, USA, 289–328 (1998).
   Google Scholar
• Steriade M, McCarley RW. Brainstem Control of Wakefulness and Sleep. Plenum Press, NY, USA (1990).
   Google Scholar
• Molle M, Marshall L, Fehm HL, Born J. EEG theta synchronization conjoined with α desynchronization indicate intentional encoding. Eur. J. Neurosci.15(5), 923–928 (2002).
   PubMed Web of Science ®Google Scholar
• Basar E, Basar-Eroglu C, Karakas S, Schurmann M. Gamma, α, delta, and theta oscillations govern cognitive processes. Int. J. Psychophysiol.39(2–3), 241–248 (2001).
   PubMed Web of Science ®Google Scholar
• Wright JJ. Brain dynamics: modeling the whole brain in action. In: Integrative Neuroscience: “Bringing Together Biological Psychological and Clinical Models of the Human Brain”. Gordon E (Ed.). Harwood Academic Publishers, Amsterdam, The Netherlands, 139–162 (2000).
   Google Scholar
• Nunez PL. Neocortical Dynamics and Human EEG Rhythms, Oxford University Press, NY, USA (1995).
   Google Scholar
• Lopes da Silva FH, Mesulam MM. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr. Clin. Neurophysiol.76, 481–508 (1990).
   PubMedGoogle Scholar
• Rowe DL, Robinson PA, Rennie CJ. Estimation of neurophysiological parameters from the waking EEG using a biophysical model of brain dynamics. J. Theor. Biol.231(3), 413–433 (2004).
   PubMed Web of Science ®Google Scholar
• McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex. J. Clin. Neurophysiol.9(2), 212–223 (1992).
   PubMed Web of Science ®Google Scholar
• Whishaw IQ, Robinson TE, Schallert T, De Ryck M, Ramirez VD. Electrical activity of the hippocampus and neocortex in rats depleted of brain dopamine and norepinephrine: relations to behavior and effects of atropine. Exp. Neurol.62(3), 748–767 (1978).
   PubMed Web of Science ®Google Scholar
• Dringenberg HC, Vanderwolf CH. Involvement of direct and indirect pathways in electrocorticographic activation. Neurosci. Biobehav. Rev.22(2), 243–257 (1998).
   PubMed Web of Science ®Google Scholar
• Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog. Neurobiol.63(6), 637–672 (2001).
   PubMed Web of Science ®Google Scholar
• Grillner P, Mercuri NB. Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav. Brain Res.130(1–2), 149–169 (2002).
   PubMed Web of Science ®Google Scholar
• Miller RJ. Presynaptic receptors. Ann. Rev. Pharmacol. Toxicol.38, 201–227 (1998).
   PubMed Web of Science ®Google Scholar
• Vanderwolf CH. Cerebral activity and behavior: control by central cholinergic and serotonergic systems. Int. Rev. Neurobiol.30, 225–340 (1988).
   PubMed Web of Science ®Google Scholar
• Dringenberg HC. Alzheimer’s disease: more than a ‘cholinergic disorder’ – evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav. Brain Res.115(2), 235–249 (2000).
   PubMed Web of Science ®Google Scholar
• Duque A, Balatoni B, Detari L, Zaborszky L. EEG correlation of the discharge properties of identified neurons in the basal forebrain. J. Neurophysiol.84(3), 1627–1635 (2000).
   PubMed Web of Science ®Google Scholar
• Berntson GG, Shafi R, Sarter M. Specific contributions of the basal forebrain corticopetal cholinergic system to electroencephalographic activity and sleep/waking behaviour. Eur. J. Neurosci.16(12), 2453–2461 (2002).
   PubMed Web of Science ®Google Scholar
• Vanderwolf CH, Baker GB. Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior. Brain Res.374(2), 342–356 (1986).
   PubMed Web of Science ®Google Scholar
• Vanderwolf CH, Leung LW, Baker GB, Stewart DJ. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine. Brain Res.504(2), 181–191 (1989).
   PubMed Web of Science ®Google Scholar
• Vanderwolf CH. The electrocorticogram in relation to physiology and behavior: a new analysis. Electroencephalogr. Clin. Neurophysiol.82(3), 165–175 (1992).
   PubMedGoogle Scholar
• Kolmac CI, Mitrofanis J. Patterns of brainstem projection to the thalamic reticular nucleus. J. Comp. Neurol.396(4), 531–543 (1998).
   PubMed Web of Science ®Google Scholar
• Lavoie B, Parent A. Serotoninergic innervation of the thalamus in the primate: an immunohistochemical study. J. Comp. Neurol.312(1), 1–18 (1991).
   PubMed Web of Science ®Google Scholar
• Dori IE, Dinopoulos A, Parnavelas JG. The development of the synaptic organization of the serotonergic system differs in brain areas with different functions. Exp. Neurol.154(1), 113–125 (1998).
   PubMed Web of Science ®Google Scholar
• Cassel JC, Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience69(1), 1–41 (1995).
   PubMed Web of Science ®Google Scholar
• Gasbarri A, Sulli A, Pacitti C, McGaugh JL. Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat. Neuroscience91(3), 1129–1142 (1999).
   PubMed Web of Science ®Google Scholar
• Steininger TL, Wainer BH, Blakely RD, Rye DB. Serotonergic dorsal raphe nucleus projections to the cholinergic and noncholinergic neurons of the pedunculopontine tegmental region: a light and electron microscopic anterograde tracing and immunohistochemical study. J. Comp. Neurol.382(3), 302–322 (1997).
   PubMed Web of Science ®Google Scholar
• Fillion G. Potential of 5-HT-moduline as a drug target for affective disorders. Curr. Opin. Invest. Drugs1(1), 104–109 (2000).
   PubMedGoogle Scholar
• Funada M, Hara C. Differential effects of psychological stress on activation of the 5-hydroxytryptamine- and dopamine-containing neurons in the brain of freely moving rats. Brain Res.901(1–2), 247–251 (2001).
   PubMed Web of Science ®Google Scholar
• Reynolds CF. Sleep, mood, and serotonin: knitting up the raveled sleeve of care. Sleep Med. Rev.6(5), 337–339 (2002).
   Web of Science ®Google Scholar
• Ruotsalainen S, Miettinen R, MacDonald E, Koivisto E, Sirvio J. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion. Psychopharmacologia148(2), 111–123 (2000).
   PubMed Web of Science ®Google Scholar
• Sugita S, Shen KZ, North RA. 5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala. Neuron8(1), 199–203 (1992).
   PubMed Web of Science ®Google Scholar
• Andersen SL, Teicher MH. Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats. Neuroreport10(17), 3497–3500 (1999).
   PubMed Web of Science ®Google Scholar
• Akirav I, Richter-Levin G. Mechanisms of amygdala modulation of hippocampal plasticity. J. Neurosci.22(22), 9912–9921 (2002).
   PubMed Web of Science ®Google Scholar
• Gottesmann C, Joncas S. Letter to the editor: hypothesis for the neurophysiology of dreaming. Sleep Res. Online3(1), 1–4 (2000).
   PubMedGoogle Scholar
• Gottesmann C. The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis. Psychiatry Clin. Neurosci.56(4), 345–354 (2002).
   PubMed Web of Science ®Google Scholar
• Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron36(2), 229–240 (2002).
   PubMed Web of Science ®Google Scholar
• Salamone JD, Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res.137(1–2), 3–25 (2002).
   PubMed Web of Science ®Google Scholar
• Robbins TW. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp. Brain Res.133(1), 130–138 (2000).
   PubMed Web of Science ®Google Scholar
• Stuss DT, Knight RT. Principles of Frontal Lobe Function. Oxford University Press, London, UK (2002).
   Google Scholar
• Smiley JF, Subramanian M, Mesulam M-M. Monoaminergic-cholinergic interactions in the primate basal forebrain. Neuroscience93(3), 817–829 (1999).
   PubMed Web of Science ®Google Scholar
• Levin ED, Simon BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacologia138(3–4), 217–230 (1998).
   PubMed Web of Science ®Google Scholar
• Casamenti F, Deffenu G, Abbamondi AL, Pepeu G. Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res. Bull.16(5), 689–695 (1986).
   PubMed Web of Science ®Google Scholar
• Miller AD, Forster GL, Metcalf KM, Blaha CD. Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors. Neuroscience111(2), 351–362 (2002).
   PubMed Web of Science ®Google Scholar
• Charara A, Smith Y, Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J. Comp. Neurol.364(2), 254–266 (1996).
   PubMed Web of Science ®Google Scholar
• Blaha CD, Allen LF, Das S et al. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J. Neurosci.16(2), 714–722 (1996).
   PubMed Web of Science ®Google Scholar
• Jackson MB. Presynaptic excitability. Int. Rev. Neurobiol.38, 201–251 (1995).
   PubMed Web of Science ®Google Scholar
• Sherman SM. Dual response modes in lateral geniculate neurons: mechanisms and functions. Visual Neuroscience13(2), 205–213 (1996).
   PubMed Web of Science ®Google Scholar
• McCormick DA. Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus. J. Neurosci.12(1), 278–289 (1992).
   PubMed Web of Science ®Google Scholar
• Meir A, Ginsburg S, Butkevich A et al. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol. Rev.79(3), 1019–1088 (1999).
   PubMed Web of Science ®Google Scholar
• Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiatry49(3), 166–174 (2001).
   PubMed Web of Science ®Google Scholar
• MacDermott AB, Role LW, Siegelbaum SA. Presynaptic ionotropic receptors and the control of transmitter release. Ann. Rev. Neurosci.22, 443–485 (1999).
   PubMed Web of Science ®Google Scholar
• Lambe EK, Picciotto MR, Aghajanian GK. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology28(2), 216–225 (2003).
   PubMed Web of Science ®Google Scholar
• Zhu PJ, Chiappinelli VA. Nicotinic receptors mediate increased GABA release in brain through a tetrodotoxin-insensitive mechanism during prolonged exposure to nicotine. Neuroscience115(1), 137–144 (2002).
   PubMed Web of Science ®Google Scholar
• Fabian-Fine R, Skehel P, Errington ML et al. Ultrastructural distribution of the α7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci.21(20), 7993–8003 (2001).
   PubMed Web of Science ®Google Scholar
• Hatton GI, Yang QZ. Synaptic potentials mediated by α 7 nicotinic acetylcholine receptors in supraoptic nucleus. J. Neurosci.22(1), 29–37 (2002).
   PubMed Web of Science ®Google Scholar
• Levy RB, Aoki C. α 7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci.22(12), 5001–5015 (2002).
   PubMed Web of Science ®Google Scholar
• Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol.61(1), 75–111 (2000).
   PubMed Web of Science ®Google Scholar
• Vernino S, Amador M, Luetje CW, Patrick J, Dani JA. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron8(1), 127–134 (1992).
   PubMed Web of Science ®Google Scholar
• Dani JA, Mayer ML. Structure and function of glutamate and nicotinic acetylcholine receptors. Curr. Opin. Neurobiol.5(3), 310–317 (1995).
   PubMed Web of Science ®Google Scholar
• Mulle C, Lena C, Changeux JP. Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron8(5), 937–945 (1992).
   PubMed Web of Science ®Google Scholar
• Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M. Direct evidence that release-stimulating α7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J. Neurochem.80(6), 1071–1078 (2002).
   PubMed Web of Science ®Google Scholar
• Alkondon M, Albuquerque EX. Nicotinic acetylcholine receptor α7 and α4β2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J. Neurophysiol.86(6), 3043–3055 (2001).
   PubMed Web of Science ®Google Scholar
• Puttfarcken PS, Jacobs I, Faltynek CR. Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum. Neuropharmacology39(13), 2673–2680 (2000).
   PubMed Web of Science ®Google Scholar
• Yokotani K, Wang M, Okada S, Murakami Y, Hirata M. Characterization of nicotinic acetylcholine receptor-mediated noradrenaline release from the isolated rat stomach. Eur. J. Pharmacol.402(3), 223–229 (2000).
   PubMed Web of Science ®Google Scholar
• Reuben M, Clarke PB. Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology39(2), 290–299 (2000).
   PubMed Web of Science ®Google Scholar
• Mihailescu S, Guzman-Marin R, Dominguez MC, Drucker-Colin R. Mechanisms of nicotine actions on dorsal raphe serotoninergic neurons. Eur. J. Pharmacol.452(1), 77–82 (2002).
   PubMed Web of Science ®Google Scholar
• Xiang Z, Huguenard JR, Prince DA. Cholinergic switching within neocortical inhibitory networks. Science281(5379), 985–988 (1998).
   PubMed Web of Science ®Google Scholar
• Barazangi N, Role LW. Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala. J. Neurophysiol.86(1), 463–474 (2001).
   PubMed Web of Science ®Google Scholar
• Nobili L, Sannita WG. Cholinergic modulation, visual function and Alzheimer’s dementia. Vision Research37(24), 3559–3571 (1997).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Wong J, Spencer TJ, Prince JB. Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series. J. Child Adolesc. Psychopharmacol.10(3), 217–222 (2000).
   PubMed Web of Science ®Google Scholar
• Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci.20(2), 92–98 (1997).
   PubMed Web of Science ®Google Scholar
• Role LW, Berg DK. Nicotinic receptors in the development and modulation of CNS synapses. Neuron16(6), 1077–1085 (1996).
   PubMed Web of Science ®Google Scholar
• Eddins D, Sproul AD, Lyford LK, McLaughlin JT, Rosenberg RL. Glutamate 172, essential for modulation of L247T α7 ACh receptors by Ca2+, lines the extracellular vestibule. Am. J. Physiol. Cell Physiol.283(5), C1454–C1460 (2002).
   Google Scholar
• Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties, and distribution of rat brain α 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci.13(2), 596–604 (1993).
   PubMed Web of Science ®Google Scholar
• Liu QS, Kawai H, Berg DK. β-amyloid peptide blocks the response of α 7-containing nicotinic receptors on hippocampal neurons. Proc. Natl Acad. Sci.98(8), 4734–4739 (2001).
   PubMed Web of Science ®Google Scholar
• Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV. Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci.18(20), 8228–8235 (1998).
   PubMed Web of Science ®Google Scholar
• Newman J. Thalamic contributions to attention and consciousness. Conscious. Cogn.4(2), 172–193 (1995).
   PubMed Web of Science ®Google Scholar
• Mitchell AS, Dalrymple-Alford JC, Christie MA. Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus. J. Neurosci.22(5), 1922–1928 (2002).
   PubMed Web of Science ®Google Scholar
• Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G. The role of locus coeruleus in the regulation of cognitive performance. Science283(5401), 549–554 (1999).
   PubMed Web of Science ®Google Scholar
• Aston-Jones G, Rajkowski J, Kubiak P, Alexinsky T. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J. Neurosci.14(7), 4467–4480 (1994).
   PubMed Web of Science ®Google Scholar
• Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl Acad. Sci. USA77(5), 3033–3037 (1980).
   PubMed Web of Science ®Google Scholar
• Reese NB, Garcia-Rill E, Skinner RD. The pedunculopontine nucleus – auditory input, arousal and pathophysiology. Prog. Neurobiol.47(2), 105–133 (1995).
   PubMed Web of Science ®Google Scholar
• Krout KE, Belzer RE, Loewy AD. Brainstem projections to midline and intralaminar thalamic nuclei of the rat. J. Comp. Neurol.448(1), 53–101 (2002).
   PubMed Web of Science ®Google Scholar
• McAlonan K, Brown VJ, Bowman EM. Thalamic reticular nucleus activation reflects attentional gating during classical conditioning. J. Neurosci.20(23), 8897–8901 (2000).
   PubMed Web of Science ®Google Scholar
• Groenewegen HJ. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience24(2), 379–431 (1988).
   PubMed Web of Science ®Google Scholar
• Matsumura M, Nambu A, Yamaji Y et al. Organization of somatic motor inputs from the frontal lobe to the pedunculopontine tegmental nucleus in the macaque monkey. Neuroscience98(1), 97–110 (2000).
   PubMed Web of Science ®Google Scholar
• Clarke NP, Bevan MD, Cozzari C, Hartman BK, Bolam JP. Glutamate-enriched cholinergic synaptic terminals in the entopeduncular nucleus and subthalamic nucleus of the rat. Neuroscience81(2), 371–385 (1997).
   PubMed Web of Science ®Google Scholar
• Higo S, Matsuyama T, Kawamura S. Direct projections from the pedunculopontine and laterodorsal tegmental nuclei to area 17 of the visual cortex in the cat. Neurosci. Res.26(2), 109–118 (1996).
   PubMed Web of Science ®Google Scholar
• Reese NB, Garcia-Rill E, Skinner RD. Auditory input to the pedunculopontine nucleus: II. Unit responses. Brain Res. Bull.37(3), 265–273 (1995).
   PubMed Web of Science ®Google Scholar
• Inglis WL, Olmstead MC, Robbins TW. Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behav. Brain Res.123(2), 117–131 (2001).
   PubMed Web of Science ®Google Scholar
• Steckler T, Inglis W, Winn P, Sahgal A. The pedunculopontine tegmental nucleus: a role in cognitive processes? Brain Res. Rev.19(3), 298–318 (1994).
   PubMedGoogle Scholar
• Uhlrich DJ, Tamamaki N, Murphy PC, Sherman SM. Effects of brain stem parabrachial activation on receptive field properties of cells in the cat’s lateral geniculate nucleus. J. Neurophysiol.73(6), 2428–2447 (1995).
   PubMed Web of Science ®Google Scholar
• Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H. Learning disturbances following excitotoxic lesion of cholinergic pedunculo-pontine nucleus in the rat. Brain Res.544(1), 126–132 (1991).
   PubMed Web of Science ®Google Scholar
• Dunbar JS, Hitchcock K, Latimer M et al. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions. Brain Res.589(2), 194–206 (1992).
   PubMed Web of Science ®Google Scholar
• Sakai K. Some anatomical and physiological properties of ponto-mesencephalic tegmental neurons with special reference to the PGO waves and postural atonia during paradoxical sleep in the cat. In: The Reticular Formation Revisited. Hobson JA, Brazier MAB (Eds). Raven Press, NY, USA, 427–447 (1980).
   Google Scholar
• Dormont JF, Conde H, Farin D. The role of the pedunculopontine tegmental nucleus in relation to conditioned motor performance in the cat. I. Context-dependent and reinforcement-related single unit activity. Exp. Brain Res.121(4), 401–410 (1998).
   PubMed Web of Science ®Google Scholar
• Koch M, Kungel M, Herbert H. Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat. Exp. Brain Res.97(1), 71–82 (1993).
   PubMed Web of Science ®Google Scholar
• Gil Z, Connors BW, Amitai Y. Differential regulation of neocortical synapses by neuromodulators and activity. Neuron19(3), 679–686 (1997).
   PubMed Web of Science ®Google Scholar
• Lavine N, Reuben M, Clarke PB. A population of nicotinic receptors is associated with thalamocortical afferents in the adult rat: laminal and areal analysis. J. Comp. Neurol.380(2), 175–190 (1997).
   PubMed Web of Science ®Google Scholar
• Broide RS, Robertson RT, Leslie FM. Regulation of α7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents. J. Neurosci.16(9), 2956–2971 (1996).
   PubMed Web of Science ®Google Scholar
• Lubin M, Erisir A, Aoki C. Ultrastructural immunolocalization of the α7 nAChR subunit in guinea pig medial prefrontal cortex. Ann. NY Acad. Sci.868, 628–632 (1999).
   PubMed Web of Science ®Google Scholar
• Hasselmo ME, Fehlau BP. Differences in time course of ACh and GABA modulation of excitatory synaptic potentials in slices of rat hippocampus. J. Neurophysiol.86(4), 1792–1802 (2001).
   PubMed Web of Science ®Google Scholar
• Sahin M, Bowen WD, Donoghue JP. Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions. Brain Res.579(1), 135–147 (1992).
   PubMed Web of Science ®Google Scholar
• Kimura F, Fukuda M, Tsumoto T. Acetylcholine suppresses the spread of excitation in the visual cortex revealed by optical recording: possible differential effect depending on the source of input. Eur. J. Neurosci.11(10), 3597–3609 (1999).
   PubMed Web of Science ®Google Scholar
• Vidal C, Changeux JP. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro.Neuroscience56(1), 23–32 (1993).
   PubMed Web of Science ®Google Scholar
• Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Austr. NZ J. Psychiatry25(2), 277–283 (1991).
   PubMed Web of Science ®Google Scholar
• Kimura F. Cholinergic modulation of cortical function: a hypothetical role in shifting the dynamics in cortical network. Neurosci. Res.38(1), 19–26 (2000).
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T. Non-stimulant treatments for ADHD. Eur. Child Adolesc. Psychiatry9(Suppl. 1), I51–I59 (2000).
   Web of Science ®Google Scholar
• Rowe DL, Robinson PA, Lazzaro I, Williams LM, Gordon E. Biophysical modelling of tonic measures of cortical activity (EEG) in attention deficit hyperactivity disorder (ADHD). Int. J. Neurosci.115(9), 1273–1305 (2005).
   PubMed Web of Science ®Google Scholar
• Conners CK, Levin ED, Sparrow E et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol. Bull.32(1), 67–73 (1996).
   PubMed Web of Science ®Google Scholar
• Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. J. Neurosci.20(1), 66–75 (2000).
   PubMed Web of Science ®Google Scholar
• Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J. Am. Acad. Child. Adolesc. Psychiatry41(7), 799–805 (2002).
   PubMed Web of Science ®Google Scholar
• Dunbar G, Demazieres A, Monreal A et al. Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers. J. Clin. Pharmacol.46(7), 715–726 (2006).
   PubMed Web of Science ®Google Scholar
• Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin. Neurophysiol.114(2), 171–183 (2003).
   PubMed Web of Science ®Google Scholar
• Amzica F, Steriade M. Electrophysiological correlates of sleep delta waves. Electroencephalogr. Clin. Neurophysiol.107(2), 69–83 (1998).
   PubMedGoogle Scholar
• Rowell PP, Volk KA, Li J, Bickford ME. Investigations of the cholinergic modulation of gaba release in rat thalamus slices. Neuroscience116(2), 447–453 (2003).
   PubMed Web of Science ®Google Scholar
• Hu B, Steriade M, Deschenes M. The effects of brainstem peribrachial stimulation on perigeniculate neurons: the blockage of spindle waves. Neuroscience31(1), 1–12 (1989).
   PubMed Web of Science ®Google Scholar
• Steriade M. Corticothalamic resonance, states of vigilance and mentation. Neuroscience101(2), 243–276 (2000).
   PubMed Web of Science ®Google Scholar
• Barry RJ, Johnstone SJ, Clarke AR. A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials. Clin. Neurophysiol.114(2), 184–198 (2003).
   PubMed Web of Science ®Google Scholar
• Wang YP, Kawai Y, Nakashima K. Rabbit P300-like potential depends on cortical muscarinic receptor activation. Neuroscience89(2), 423–427 (1999).
   PubMed Web of Science ®Google Scholar
• Hammond EJ, Meador KJ, Aung-Din R, Wilder BJ. Cholinergic modulation of human P3 event-related potentials. Neurology37(2), 346–350 (1987).
   PubMed Web of Science ®Google Scholar
• Pineda JA, Herrera C, Kang C, Sandler A. Effects of cigarette smoking and 12-h abstention on working memory during a serial-probe recognition task. Psychopharmacology139(4), 311–321 (1998).
   PubMed Web of Science ®Google Scholar
• Pineda JA, Westerfield M. Monkey P3 in an “oddball” paradigm: pharmacological support for multiple neural sources. Brain Res. Bull.31(6), 689–696 (1993).
   PubMed Web of Science ®Google Scholar
• Potter DD, Pickles CD, Roberts RC, Rugg MD. Scopolamine impairs memory performance and reduces frontal but not parietal visual P3 amplitude. Biol. Psychol.52(1), 37–52 (2000).
   PubMed Web of Science ®Google Scholar
• Rennie CJ, Robinson PA, Wright JJ. Unified neurophysiological model of EEG spectra and evoked potentials. Biol. Cybern.86(6), 457–471 (2002).
   PubMed Web of Science ®Google Scholar
• Lee KH, McCormick DA. Acetylcholine excites GABAergic neurons of the ferret perigeniculate nucleus through nicotinic receptors. J. Neurophysiol.73(5), 2123–2128 (1995).
   PubMed Web of Science ®Google Scholar
• Zhu JJ, Uhlrich DJ. Nicotinic receptor-mediated responses in relay cells and interneurons in the rat lateral geniculate nucleus. Neuroscience80(1), 191–202 (1997).
   PubMed Web of Science ®Google Scholar
• Castro-Alamancos MA, Calcagnotto ME. High-pass filtering of corticothalamic activity by neuromodulators released in the thalamus during arousal: in vitro and in vivo.J. Neurophysiol.85(4), 1489–1497 (2001).
   PubMed Web of Science ®Google Scholar
• Castro-Alamancos MA. Properties of primary sensory (lemniscal) synapses in the ventrobasal thalamus and the relay of hig-frequency sensory inputs. J. Neurophysiol.87(2), 946–953 (2002).
   PubMed Web of Science ®Google Scholar
• Clarke AR, Barry RJ, McCarthy R et al. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder predominantly inattentive type. Int. J. Psychophysiol.47(2), 129–137 (2003).
   PubMed Web of Science ®Google Scholar
• Mazurov A, Hauser T, Miller CH. Selective α7 nicotinic acetylcholine receptor ligands. Curr. Med. Chem.13(13), 1567–1584 (2006).
   PubMed Web of Science ®Google Scholar
• Frazier TW, Demaree HA, Youngstrom EA. Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology18(3), 543–555 (2004).
   PubMed Web of Science ®Google Scholar
• Rowe DL, Robinson PA, Gordon E. Stimulant drug action in attention deficit hyperactivity disorder (ADHD): inference of neurophysiological mechanisms via quantitative modelling. Clin. Neurophysiol.116, 324–335 (2004).
   Web of Science ®Google Scholar
• Purper-Ouakil D, Fourneret P, Wohl M, Reneric JP. Atomoxetine: a new treatment for attention deficit/hyperactivity disorder (ADHD) in children and adolescents. Encephale31(3), 337–348 (2005).
   PubMed Web of Science ®Google Scholar
• Buitelaar JK, Michelson D, Danckaerts M et al. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol. Psychiatry (2006) (In Press).
   PubMed Web of Science ®Google Scholar
• Woodcock J. Pharmacogenetics: on the road to ‘personalized medicine’. FDA Consumer39(6), 44 (2005).
   PubMedGoogle Scholar
• Iorga B, Herlem D, Barr E, Guillou C. Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the “blind docking” approach. J. Mol. Model.12(3), 366–372 (2006).
   PubMed Web of Science ®Google Scholar
• Hay BP, Firman TK, Lumetta GJ et al. Toward the computer-aided design of metal ion sequestering agents. J. Alloys Compounds374(1–2), 416–419 (2004).
   Web of Science ®Google Scholar
• Ortiz AR, Gomez-Puertas P, Leo-Macias A et al. Computational approaches to model ligand selectivity in drug design. Curr. Top. Medicinal Chem.6(1), 41–55 (2006).
   PubMed Web of Science ®Google Scholar